Allurion Technologies (ALURD) Operating Income (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Operating Income came in at -$3.7 million in Q1 2026, up 48.76% YoY from -$2.5 million in Q1 2025, and up 40.37% on a QoQ basis from -$6.3 million in Q4 2025.
Allurion Technologies (ALURD) Operating Income (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Operating Income data on file, last reported at -$3.7 million in Q1 2026.
- Quarterly Operating Income rose 48.76% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.6 million (up 42.34% YoY) and the FY2025 annual result came in at -$30.2 million, up 39.92% from the prior year.
- Operating Income advanced to -$3.7 million in Q1 2026, from -$6.3 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$3.7 million in Q1 2026 to a low of -$26.2 million in Q3 2023.
- A 5-year average of -$11.8 million and a median of -$10.8 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income slumped 209.67% — and 2025, when it jumped 63.44%.
- Tracing ALURD's Operating Income over 5 years: stood at -$10.1 million in 2022, then plunged by 153.63% to -$25.7 million in 2023, then soared by 33.5% to -$17.1 million in 2024, then jumped by 63.44% to -$6.3 million in 2025, then surged by 40.37% to -$3.7 million in 2026.
- The last three Operating Income figures came in at -$3.7 million (Q1 2026), -$6.3 million (Q4 2025), and -$9.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.73 Mn |
| Dec 31, 2025 | -6.26 Mn |
| Sep 30, 2025 | -9.63 Mn |
| Jun 30, 2025 | -6.95 Mn |
| Mar 31, 2025 | -7.28 Mn |
| Dec 31, 2024 | -17.12 Mn |
| Sep 30, 2024 | -12.34 Mn |
| Jun 30, 2024 | -9.35 Mn |
| Mar 31, 2024 | -11.39 Mn |
| Dec 31, 2023 | -25.74 Mn |
| Sep 30, 2023 | -26.15 Mn |
| Jun 30, 2023 | -13.29 Mn |
| Mar 31, 2023 | -13.90 Mn |
| Dec 31, 2022 | -10.15 Mn |
| Sep 30, 2022 | -11.99 Mn |
| Jun 30, 2022 | -4.29 Mn |